Ute I. Schwarz

7.5k total citations
87 papers, 5.6k citations indexed

About

Ute I. Schwarz is a scholar working on Oncology, Pharmacology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Ute I. Schwarz has authored 87 papers receiving a total of 5.6k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Oncology, 26 papers in Pharmacology and 19 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Ute I. Schwarz's work include Drug Transport and Resistance Mechanisms (27 papers), Pharmacogenetics and Drug Metabolism (25 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Ute I. Schwarz is often cited by papers focused on Drug Transport and Resistance Mechanisms (27 papers), Pharmacogenetics and Drug Metabolism (25 papers) and Pharmacological Effects and Toxicity Studies (15 papers). Ute I. Schwarz collaborates with scholars based in Canada, United States and Germany. Ute I. Schwarz's co-authors include Richard B. Kim, George K. Dresser, Rommel G. Tirona, Kerstin Amann, Brenda F. Leake, David G. Bailey, C. Michael Stein, Dan M. Roden, Marylyn D. Ritchie and Gerhard Mall and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Ute I. Schwarz

84 papers receiving 5.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ute I. Schwarz Canada	37	2.0k	1.9k	1.2k	863	733	87	5.6k
Noriaki Shimada Japan	57	2.4k 1.2×	1.4k 0.7×	455 0.4×	381 0.4×	1.8k 2.4×	207	9.6k
C. Michael Stein United States	36	1.6k 0.8×	942 0.5×	571 0.5×	2.1k 2.5×	1.0k 1.4×	68	7.0k
George K. Dresser Canada	28	1.4k 0.7×	1.5k 0.8×	886 0.7×	436 0.5×	518 0.7×	59	3.9k
Ron H. N. van Schaik Netherlands	53	2.8k 1.4×	2.7k 1.4×	2.2k 1.8×	427 0.5×	2.1k 2.9×	242	9.3k
AM Breckenridge United Kingdom	47	1.7k 0.9×	779 0.4×	1.1k 0.9×	559 0.6×	564 0.8×	157	5.8k
In‐Jin Jang South Korea	40	1.2k 0.6×	1.6k 0.8×	777 0.7×	293 0.3×	1.5k 2.0×	306	5.9k
Stuart A. Scott United States	46	4.3k 2.2×	1.1k 0.6×	1.7k 1.5×	1.4k 1.6×	1.8k 2.4×	141	8.8k
Ichiro Ieiri Japan	45	2.1k 1.1×	3.3k 1.7×	1.9k 1.6×	237 0.3×	1.2k 1.7×	176	6.4k
Yukiya Hashimoto Japan	32	621 0.3×	1.4k 0.7×	873 0.7×	561 0.7×	602 0.8×	127	3.1k
Christian Funck‐Brentano France	47	1.6k 0.8×	1.3k 0.7×	645 0.5×	3.4k 3.9×	1.3k 1.8×	205	7.7k

Countries citing papers authored by Ute I. Schwarz

Since Specialization

Citations

This map shows the geographic impact of Ute I. Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ute I. Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ute I. Schwarz more than expected).

Fields of papers citing papers by Ute I. Schwarz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ute I. Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ute I. Schwarz. The network helps show where Ute I. Schwarz may publish in the future.

Co-authorship network of co-authors of Ute I. Schwarz

This figure shows the co-authorship network connecting the top 25 collaborators of Ute I. Schwarz. A scholar is included among the top collaborators of Ute I. Schwarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ute I. Schwarz. Ute I. Schwarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schwarz, Ute I., et al.. (2025). NFIB rs28379954 does not affect CYP2D6-mediated metabolism of prototypical substrates, tamoxifen or solanidine. Pharmacogenetics and Genomics. 36(3). 83–87.

Schwarz, Ute I., Guangyong Zou, Eric McArthur, et al.. (2023). Does prescribing apixaban or rivaroxaban versus warfarin for patients diagnosed with atrial fibrillation save health system costs? A multivalued treatment effects analysis. The European Journal of Health Economics. 25(3). 397–409. 2 indexed citations

Schwarz, Ute I., Chantel Cacciotti, Elizabeth Cairney, et al.. (2023). Thiopurine Methyltransferase Intermediate Metabolizer Status and Thiopurine‐Associated Toxicity During Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia. Clinical Pharmacology & Therapeutics. 113(6). 1326–1336. 2 indexed citations

Cipriano, Lauren E., et al.. (2023). Cost-Effectiveness Analysis of Pharmacogenomics (PGx)-Based Warfarin, Apixaban, and Rivaroxaban Versus Standard Warfarin for the Management of Atrial Fibrillation in Ontario, Canada. PharmacoEconomics. 42(1). 69–90. 1 indexed citations

Loucks, Catrina M., Britt I. Drögemöller, Galen E.B. Wright, et al.. (2021). Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment. Biomedicine & Pharmacotherapy. 143. 112195–112195. 2 indexed citations

Lizotte, Daniel J., George K. Dresser, Jeffrey Alfonsi, et al.. (2019). Drug interactions and pharmacogenetic factors contribute to variation in apixaban concentration in atrial fibrillation patients in routine care. Journal of Thrombosis and Thrombolysis. 49(2). 294–303. 38 indexed citations

Robertson, Brian D., Alex A. MacDonald, Ken N. Seergobin, et al.. (2018). SLC6A3 Polymorphism Predisposes to Dopamine Overdose in Parkinson's Disease. Frontiers in Neurology. 9. 693–693. 12 indexed citations

Kim, Michelle, Rommel G. Tirona, Richard B. Kim, et al.. (2017). Characterization of OATP1B3 and OATP2B1 transporter expression in the islet of the adult human pancreas. Histochemistry and Cell Biology. 148(4). 345–357. 10 indexed citations

Steffen, Robert, Jakob P. Cramer, Gerd Burchard, et al.. (2013). Efficacy of a Travelers' Diarrhea Vaccine System in Travelers to India: Table 1. Journal of Travel Medicine. 20(6). 374–379. 18 indexed citations

10.

Gong, Inna Y., Ute I. Schwarz, Natalie Crown, et al.. (2011). Clinical and Genetic Determinants of Warfarin Pharmacokinetics and Pharmacodynamics during Treatment Initiation. PLoS ONE. 6(11). e27808–e27808. 62 indexed citations

11.

Schwabedissen, Henriette E. Meyer zu, Joseph A. Ware, David Finkelstein, et al.. (2011). Hepatic organic anion transporting polypeptide transporter and thyroid hormone receptor interplay determines cholesterol and glucose homeostasis. Hepatology. 54(2). 644–654. 23 indexed citations

12.

Knauer, Michael J., Bradley L. Urquhart, Henriette E. Meyer zu Schwabedissen, et al.. (2009). Human Skeletal Muscle Drug Transporters Determine Local Exposure and Toxicity of Statins. Circulation Research. 106(2). 297–306. 176 indexed citations

13.

Schwarz, Ute I., Reinhard Oertel, Stephan Miehlke, et al.. (2007). Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol. Clinical Pharmacology & Therapeutics. 81(5). 669–678. 92 indexed citations

14.

Glaeser, Hartmut, David G. Bailey, George K. Dresser, et al.. (2007). Intestinal Drug Transporter Expression and the Impact of Grapefruit Juice in Humans. Clinical Pharmacology & Therapeutics. 81(3). 362–370. 315 indexed citations

15.

Wichmann, Ole, Matthias Günther, Jakob P. Cramer, et al.. (2006). Risk and Spectrum of Diseases in Travelers to Popular Tourist Destinations. Journal of Travel Medicine. 12(5). 248–253. 98 indexed citations

16.

Schwarz, Ute I., Philip E. Johnston, David G. Bailey, et al.. (2005). Impact of citrus soft drinks relative to grapefruit juice on ciclosporin disposition. British Journal of Clinical Pharmacology. 62(4). 485–491. 24 indexed citations

17.

Kuhlmann, Alexander, Christian Haas, Marie‐Luise Gross, et al.. (2004). 1,25-Dihydroxyvitamin D₃decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat. American Journal of Physiology-Renal Physiology. 286(3). F526–F533. 181 indexed citations

18.

Schwarz, Ute I., George K. Dresser, Martin F. Fromm, et al.. (2002). St Johns wort reduces oral bioavailability of talinolol in healthy volunteers. Clinical Pharmacology & Therapeutics. 71(2). 33. 9 indexed citations

19.

Schwarz, Ute I., T Gramatté, Jutta Krappweis, Reinhard Oertel, & Wilhelm Kirch. (2000). P-glycoprotein inhibitor erythromycin increases oral bioavailability of talinolol in humans. International Journal of Clinical Pharmacology and Therapeutics. 38(4). 161–167. 118 indexed citations

20.

Schwarz, Ute I., et al.. (1999). Unexpected effect of verapamil on oral bioavailability of the β-blocker talinolol in humans. Clinical Pharmacology & Therapeutics. 65(3). 283–290. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact